HRSA Told Lilly In June To Rethink 340B Contract Pharmacy Limits, But Didn’t Outright Say Illegal

By Michelle M. Stein / November 6, 2020 at 2:01 PM
The Health Resources and Services Administration asked Eli Lilly in June to rethink its plan to stop 340B discounts for certain drugs supplied via contract pharmacies but the agency stopped short of declaring the policy illegal, according to internal correspondence between HRSA and Eli Lilly obtained by Inside Health Policy . Lilly told HRSA in May that unless the agency explicitly said the policy was illegal it would proceed, which it ended up doing. The months of internal correspondence reveal...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.